Bolt Biotherapeutics logo

Bolt Biotherapeutics


Bolt Biotherapeutics, Inc., based in the San Francisco Bay Area, is a publicly-traded biotechnology company developing Boltbody™ Immune-stimulating Antibody Conjugates (ISAC), a new class of immuno-oncology therapeutics that have eliminated tumors following systemic administration in preclinical studies and results in the development of immunological memory, which may lead to more durable clinical responses for pa...


Add photos to showcase Bolt Biotherapeutics’s culture


Add Bolt Biotherapeutics’s values

Insider experiences

Share your experience of working at Bolt Biotherapeutics

Randall Schatzman
CEO & Board Member
Grant Yonehiro
Chief Business Officer
Edith A. Perez
Chief Medical Officer
Brian Safina
VP, Chemistry
Michael N. Alonso
VP, Immunology & Pharmacology
Nathan Ihle
VP, CMC & Quality
Wesley Burwell
VP, Head of HR
Bruce Hug
SVP, Clinical Development & Translational Medicine
Sarah Nemec
VP, Finance
Karen L. Bergman
VP, Communications & Investor Relations
John Tomaro
VP, Clinical Operations
Ming Yin
VP, Head of Biometrics
Lu Xu
VP, Developmental Science

Add your teams to show how people work together at Bolt Biotherapeutics

Add jobs to your org chart to show candidates who they’ll work with

Publish company announcements to get more exposure